Center Status Level Assignment
The Stem Cell Therapeutic Outcomes Database (SCTOD) is part of the C.W. Bill Young Cell Transplantation Program (Program), authorized by the Stem Cell Therapeutic and Research Act of 2005 (Public Law 109-129) and reauthorized by the Stem Cell Therapeutic and Research Reauthorization Act of 2010 (Public Law 111-264), and the Stem Cell Therapeutic and Research Reauthorization Act of 2015 (Public Law 114-104).
As the contract holder, the Center for International Blood and Marrow Transplant Research (CIBMTR) is required to collect data for all allogeneic (related and unrelated) hematopoietic cell transplants (HCTs) performed in the United States, and for all HCTs utilizing a product procured through the Program, but performed outside of the United States.
The CIBMTR has established processes to assess and close any gaps that exist in data reporting to the SCTOD. To determine a member center’s participation level, the CIBMTR has established the following statuses. These participation statuses determine if a center is required to comply with the CIBMTR Continuous Process Improvement program (CPI).
A center that has registered and submitted forms for new patients during the most recent 24-month period to the CIBMTR. Active centers must have established reporting levels for each infusion type and are subject to all Continuous Process Improvement (CPI) requirements. An Active status allows for center staff to participate in CIBMTR leadership roles.
A center that has submitted forms during the most recent 24-month period but has not registered any new patients during that same time. Follow Up centers are subject to some requirements of the CPI Program. A Follow Up status allows for center staff to participate in CIBMTR leadership roles.
A center that has not submitted forms or registered new patients within the last 24-month period. Inactive centers are not subject to any CPI requirements. An Inactive status prohibits center staff from participating in CIBMTR leadership roles.